IFNA1 and systemic lupus erythematosus: To determine the relevance of interferon signature to clinical manifestations in the Stanford SLE cohort, a retrospective chart review is performed on unique patients (n=42) by a senior rheumatology fellow (GDM) who is blinded to the IFN signature status of each patient.